These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15869594)

  • 1. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.
    Ohlin AK; Larsson K; Hansson M
    J Thromb Haemost; 2005 May; 3(5):976-82. PubMed ID: 15869594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
    Kawasaki T; Okamoto K; Kawasaki C; Sata T
    Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity.
    Yokoyama H; Tateishi K; Baba Y; Kobayashi A; Hashimoto M; Fukuda S; Yamao H; Maruyama T; Nakata M; Matsushita M
    Biosci Trends; 2022 Dec; 16(6):444-446. PubMed ID: 36450579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
    Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
    Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
    Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
    Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin: an overview and potential implications in vascular disorders.
    Boffa MC; Karmochkine M
    Lupus; 1998; 7 Suppl 2():S120-5. PubMed ID: 9814688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
    Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system.
    Wolter J; Schild L; Bock F; Hellwig A; Gadi I; Al-Dabet MM; Ranjan S; Rönicke R; Nawroth PP; Petersen KU; Mawrin C; Shahzad K; Isermann B
    J Thromb Haemost; 2016 Nov; 14(11):2212-2226. PubMed ID: 27590316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis.
    Carson CW; Comp PC; Rezaie AR; Esmon NL; Esmon CT
    J Rheumatol; 2000 Feb; 27(2):384-90. PubMed ID: 10685802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
    Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
    Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO
    J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of soluble thrombomodulin levels in patients with stage 3-5 chronic kidney disease.
    Bao YS; Jia XB; Wang D; Liu RC; Zou CB; Na SP
    Biomarkers; 2014 Jun; 19(4):275-80. PubMed ID: 24854597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating thrombomodulin during radiation therapy of lung cancer.
    Hauer-Jensen M; Kong FM; Fink LM; Anscher MS
    Radiat Oncol Investig; 1999; 7(4):238-42. PubMed ID: 10492164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
    Carnemolla R; Villa CH; Greineder CF; Zaitsev S; Patel KR; Kowalska MA; Atochin DN; Cines DB; Siegel DL; Esmon CT; Muzykantov VR
    FASEB J; 2017 Feb; 31(2):761-770. PubMed ID: 27836986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
    Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between disseminated intravascular coagulation and levels of plasma thrombinogen segment 1+2, D-dimer, and thrombomodulin in patients with multiple injuries.
    Zhu YJ; Huang XK
    Chin J Traumatol; 2009 Aug; 12(4):203-9. PubMed ID: 19635212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.